Mostly Markets
Subscribe
Stocks/Health Care/Health Care Equipment

Becton DickinsonBDX

Health Care Equipment · Franklin Lakes, New Jersey · In the S&P 500
Solid businessCheaper than peers
$197.88−0.23%After hours: $197.88 (0.00%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 36.2% over 1 year
Becton Dickinson over 1 yearDaily close, $, to 30 Oct 2026
$140$160$180Nov2026MarMayJulSep$197.88$150$175NovMarJul$197.88
Source: Nasdaq daily closes
Market value$53.90B
Price to earnings43.4x
Forward P/E15.0x
Dividend yield2.12%
Year to date+27.4%
One year+36.2%
Next earningsThu 5 Nov, before the open
SectorHealth Care
52-week range (closes)
$140.71$200.42

Quality and valuation

How Becton Dickinson compares with other health care stocks. A description, not a recommendation.

Becton Dickinson and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: cheaper than most

An average business among health care companies, priced below most of them.

Becton Dickinson trades at 15.0 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +17.4% vs +7.8%
  • Keeps less of each sale (gross margin): 46.9% vs 65.3%
  • Less profitable (operating margin): 10.7% vs 13.3%
  • Turns less of its sales into cash: 13.8% vs 15.9%
BDX trades at 15.0x forward earnings, below the sector medianForward p/e, Health Care Equipment peers
BSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1xBSX13.8xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xIDXX35.1xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 59.8x earnings, BDX is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
30x40x50xAverage 33.9x2025202659.8x40xAverage 33.9x2025202659.8x
Source: Nasdaq prices; SEC filings

Financials

From Becton Dickinson's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 5.4% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$2bn$5bn$8bnQ4 ’24Q2 ’25Q4 ’25$5.0bnQ3 ’26$0bn$5bnQ4 ’24Q2 ’25Q4 ’25$5.0bnQ3 ’26
Source: SEC filings
Growth sped up to +5.4% last quarterRevenue growth, year on year, %
0%20%40%Q4 ’24Q2 ’25Q4 ’255.4%Q3 ’260%25%50%Q4 ’24Q2 ’25Q4 ’255.4%Q3 ’26
Source: SEC filings
Operating margin was 13.3% last quarterOperating income as a share of revenue, %
0%5%10%15%Q4 ’24Q2 ’25Q4 ’2513.3%Q3 ’260%10%Q4 ’24Q2 ’25Q4 ’2513.3%Q3 ’26
Source: SEC filings
Free cash flow was $3.2 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$0.0bn$0.5bn$1.0bnQ4 ’24Q2 ’25Q4 ’25$0.6bnQ3 ’26$0bn$1bnQ4 ’24Q2 ’25Q4 ’25$0.6bnQ3 ’26
Source: SEC filings
Last 12 monthsBDXSector median
Revenue growth+17.4%+7.8%
Gross margin46.9%65.3%
Operating margin10.7%13.3%
Free cash flow margin13.8%15.9%
Price to earnings43.4x30.2x

Stories on Becton Dickinson

We haven't written about Becton Dickinson yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
ISRGIntuitive Surgical$432.01−3.73%−23.7%$150B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BSXBoston Scientific$41.98−1.66%−56.0%$60.84B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B
GEHCGE HealthCare$76.57+0.20%−6.6%$34.62B